Dr. Pankaj Goyal: Medical Oncology Consultant Delhi NCR, India | Book Appointment

Dr. Pankaj Goyal

MBBS, DTCD, DNB (Internal Medicine),D.N.B (Medical Oncology), ECMO (Europe)

Senior Consultant, Medical Oncology

Book an Appointment

Rajiv Gandhi Cancer Institute, Sector - 5, Rohini, Delhi - 110 085

About

Dr Pankaj Goyal has been working in the field of Medical Oncology for past 6 years at RGCI & RC, Delhi and has more than 18 years of experience in field of medicine. He has rich experience in management of both hematological & non hematological malignancies (breast, lung and other solid tumors). He has also cleared “European Certified Medical Oncologist” exam conducted by ESMO Medical Oncology.

Dr. Pankaj has keen interest in clinical research & research ethics. He is an active member of a number of professional bodies & societies including European Society for Medical Oncology (ESMO). He has done many oral and poster presentations in national and international conferences. He also has a keen interest in the importance of excellent communication skills on the quality and outcomes of patients. His expertise spans in all types of chemotherapy, intensive protocols, immunotherapy, hormonal therapy in addition to dealing with oncological emergencies, including medical care of patients. He holds deep interest in breast cancer, lung cancer, gastro – intestinal cancer, gynaecological cancer and lymphoma / leukemia / myeloma. He was also awarded the best physician in 2015 at RGCI & RC.

Specialized Areas

Non hematological malignancies
- Breast,
- Lung and
- Other solid tumors including gastro intestinal cancer, gyanecological cancer
Hematological malignancies

Educational Background

“European Certified Medical Oncologist” (ECMO) Exam conducted by European Society of Medical Oncology.
2013 – 2016, Diplomate of National Board, Medical Oncology, R.G.C.I.R.C, Rohini, India.
2009-2012, Senior Resident in Medicine Department, BhagwanMahavir Hospital, Pitampura, Delhi managing ICU, inpatients and OPD including chest OPD and bronchoscopy.
Aug. – Nov 2008, Senior Resident in Respiratory Medicine Department, St. Stephens Hospital, Delhi Performing P.F.T and bronchoscopy.
2005-2008, D.N.B (Internal Medicine) – St. Stephens Hospital, Delhi.
2003-2005, Post Graduate Diploma in Respiratory Medicine – P.G.I.M.S, Rohtak, Haryana.
2002-2003, One Year Compulsory Rotating Internship K.M.C,Mangalore, Karnataka.
1997-2002, M.B.B.S – K.M.C, Mangalore, Karnataka, India (M.A.H.E University).

Experience

2013-2016 – Diplomate of National Board, Medical Oncology, RGCI & RC, Delhi, India. 2016
2009-2012 – Senior Resident in Medicine Department, Bhagwan Mahavir Hospital, Pitampura, Delhi.
Aug-Nov 2008 – Senior Resident in Respiratory Medicine Department, St. Stephens Hospital, Delhi.
2005-2008 – Diplomate of National Board, Internal Medicine, St. Stephens Hospital, Delhi.
2003-2005 – Post Graduate Diploma in Respiratory Medicine, P.G.I.M.S, Rohtak, Haryana.
2002-2003 – One Year Compulsory Rotating Internship K.M.C,Mangalore, Karnataka.

Professional Journey

Awards

Best Resident Doctor in Rajiv Gandhi Cancer Hospital in 2014.

Publications:

Efficacy and Toxicity Profile of Maintenance Pemetrexed in Patients with Stage IV adenocarcinoma Lung in Indian Population. Pankaj et al. South Asian J Cancer 5 (4), 196-203. Oct-Dec 2016.
Upadhyay A, Goel V, Batra U, Goyal P, Dutta K, Aggarwal M, Doval D C. Two cases of ovarian carcinoma with endobronchial metastases: Rare presentation. South Asian J Cancer 2015; 4:149.
Chandragouda D, Doval DC, Mahanta A, Goel V, Upadhyay A, Goyal P, et al. FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients. Japanese Journal of Clinical Oncology, 2015, 1-6.
Talwar V, Raina S, Goel V, Doval D. Gemcitabine and Carboplatin in Inoperable, LocoRegionally Advanced and Metastatic Gallbladder Cancer- A Study from Northern Indian Cancer Institute. British Journal of Medicine & Medical Research, 19(12): 1-7, 2017.
Pemetrexed maintenance in NSCLC — Poster Presentation at the 12th International Conference of Asian Clinical Oncology Society (ACOS) April, 2016, New Delhi.
To Assess Efficacy of First Line TKIs in EGFR Mutant Advanced NSCLC Patients from North India: Journal of Thoracic Oncology, 2016.
Epidemiology and resistance pattern of bacterial isolates among cancer patients in a tertiary care oncology centre in North India. Indian Journal of Cancer 2016.
Poster presentation in ESMO Singapore “efficacy and safety profile of Eribulin Mesylate in advanced breast cancer.
Paper presentation in RGCON 2017 awarded second best: Role of ki-67 index in breast cancer.
Review article “circulatory tumor cells in breast cancer” International journal of molecular and immune-oncology 2017.
Dash P, Goel V, Talwar V, Doval DC, Raina S, Goyal P, Upadhyay A, Patnaik N. Study of efficacy and safety of modified adjuvant intraperitoneal chemotherapy regimen in carcinoma ovary. Indian J Cancer. 2016 Oct-Dec; 53(4):607-611.